4-aminoimidazole has been researched along with Alzheimer Disease in 1 studies
4-aminoimidazole: structure in first source
4-aminoimidazole : An aminoimidazole that is 1H-imidazole substituted by an amino group at position 4.
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Helal, CJ | 1 |
| Kang, Z | 1 |
| Lucas, JC | 1 |
| Gant, T | 1 |
| Ahlijanian, MK | 1 |
| Schachter, JB | 1 |
| Richter, KE | 1 |
| Cook, JM | 1 |
| Menniti, FS | 1 |
| Kelly, K | 1 |
| Mente, S | 1 |
| Pandit, J | 1 |
| Hosea, N | 1 |
1 other study available for 4-aminoimidazole and Alzheimer Disease
| Article | Year |
|---|---|
Potent and cellularly active 4-aminoimidazole inhibitors of cyclin-dependent kinase 5/p25 for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Binding Sites; Caco-2 Cells; Crystallography, X-Ray; Cyclin E; Cyclin-De | 2009 |